Kevin Tomlinson brings global industry experience to Plymouth Minerals

Published 08-JUN-2017 10:22 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Plymouth Minerals (ASX: PLH) has strengthened its Board with the appointment of Mr Kevin Tomlinson as Non-Executive Chairman.

Tomlinson possesses over 30 years’ experience in mining and finance within the Toronto, Australian and London stock markets. He is a resident of London, England, placing him in close proximity to the San Jose lithium-tin project located in Spain.

This is a highly advanced lithium project with an established mineral resource. PLH is progressing the project towards development, and in so doing can earn up to 75% by completing a feasibility study within four years.

Tomlinson’s inclusion on the Board brings a strong mix of industry and corporate experience, as well as an extensive knowledge of a broad range of geographic regions.

His background in project finance, development and mining experience includes previous roles as Managing Director at Westwind Partners/Stifel Nicolaus (investment banking) and the Boards of Centamin Plc and Medusa Mining (mining companies).

Tomlinson will bolster the PLH board

Mr. Tomlinson

Tomlinson is also the Non-Executive Chairman of ASX-listed Cardinal Resources which is developing a large gold project.

In highlighting the valuable experience that Tomlinson possesses, PLH’s Managing Director, Adrian Byass said, “The company is excited by the addition of Mr Tomlinson to the Board and believes that his experience in project funding and development will add significant value to Plymouth’s mineral assets, led by the highly advanced San Jose lithium-tin deposit in Spain.”

It should be noted here that this is still a speculative stock and investors considering this stock for their portfolio should seek professional financial advice.

As well as earning 75% of San Jose by refreshing historic feasibility study, which involves open pit mining and a process flow sheet to produce lithium carbonate on site, PLH recently announced a maiden JORC resource and metallurgy work updates. Byass said the company plans to lodge a Mining Lease Application over San Jose in the third quarter of 2017.

PLH recently announced investment into its Spanish subsidiary holding company via London-based Reabold Resource Plc. and is investigating opportunities to create shareholder value through divestment of its highly advanced lithium-tin assets in Spain and its large, well located potash projects on the coast of Gabon.

As part of the strengthening of the Board, current Executive Chairman Adrian Byass will assume the role of Managing Director. Subject to regulatory and shareholder approval, Mr Tomlinson will receive 2 million Options over Ordinary Shares with a strike price of $0.32. Plymouth will call a shareholder meeting to seek approval to issue.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X